CLOs on the Move

BioTime

www.biotimeinc.com

 
BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.biotimeinc.com
  • 1010 Atlantic Avenue Suite 102
    Alameda, CA USA 94501
  • Phone: 510.521.3390

Executives

Name Title Contact Details
Chase Leavitt
 General Counsel and Corporate Secretary Profile

Similar Companies

Lassen Therapeutics

Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.

Valo Health

Valo Health is a biotech company that is recreating the future of medicine.

Mitra Biotech

Mitra Biotech is the global leader in therapy selection in oncology. Mitra is led by an accomplished team of diagnostic and drug development professionals and is backed by world leading venture groups with long term commitment to Mitra’s vision in personalized cancer care.

Synecor

Synecor is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MBL

MBL is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.